Tripapolon

Tripapolon. Sample pack with Data Matrix Code with the Pharmacy Product Number (PPN) on the front. The illustration corresponds to the requirements of the Therapeutic Products Advertising Act and the securPharm coding rules.

Tripapolon forte is a fictional drug name printed on a drug test pack . It was created by the association securPharm eV as part of the implementation of the so-called Counterfeit Protection Directive 2011/62 / EU of the European Union, which had to be implemented by February 9, 2019. The packaging is the same as that of a regular drug. The name printed on the active ingredient tripolonium is also fictional.

The packaging is used to test and demonstrate the test systems required by the Falsified Medicines Directive.

Verification process

When the data matrix code of the drug pack is scanned in the pharmacy, the data contained therein is recorded: batch , expiry date , central pharmaceutical number and serial number . During the inquiry process, which is forwarded to the pharmacy server, this data is supplemented by the pharmacy's data, so that it is ensured that only real pharmacies use the system. The status of the pack stored in the manufacturer's database is checked and reported back to the pharmacy. If the package is not verified, it must be classified as potentially counterfeit.

See also

• E-pedigree
• Counterfeit drugs

Individual evidence

1. ^ State of affairs securPharm , BfArM im Dialog May 8, 2018, Bonn. Retrieved November 11, 2018.
2. ↑ Delegated Regulation (EU) 2016/161 of the Commission of October 2nd, 2015 supplementing Directive 2001/83 / EC of the European Parliament and of the Council by laying down precise provisions on the safety features on the packaging of medicinal products for human use
3. ↑ forgery Policy , Federal Institute for Drugs and Medical Devices . Retrieved November 11, 2018.